Santhera Pharmaceuticals Holdings (SPHDF, $0.68) was a top loser over the last three months, falling -4 to $0.68 per share. A.I.dvisor analyzed 972 stocks in the Biotechnology Industry for the 3-month period ending April 3, 2023, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend. 443 similar cases when SPHDF's price dropped within three months. In out of those 443 cases, SPHDF's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for SPHDF are